Caplin Point Laboratories Q1 Results; stock jumps 5%




Cons net profit at Rs 124 cr
Cons revenue from operations at Rs 459 cr
Final dividend at Rs 2.5 per share
Approved re-appointment of Sridhar Ganesan as MD

Comments